T

TOT BIOPHARM International Co Ltd
HKEX:1875

Watchlist Manager
TOT BIOPHARM International Co Ltd
HKEX:1875
Watchlist
Price: 2.5 HKD 19.05% Market Closed
Market Cap: 1.9B HKD

Intrinsic Value

The intrinsic value of one TOT BIOPHARM International Co Ltd stock under the Base Case scenario is 3.84 HKD. Compared to the current market price of 2.5 HKD, TOT BIOPHARM International Co Ltd is Undervalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3.84 HKD
Undervaluation 35%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
TOT BIOPHARM International Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about TOT BIOPHARM International Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TOT BIOPHARM International Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for TOT BIOPHARM International Co Ltd.

Explain Valuation
Compare TOT BIOPHARM International Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TOT BIOPHARM International Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
TOT BIOPHARM International Co Ltd

Balance Sheet Decomposition
TOT BIOPHARM International Co Ltd

Current Assets 746.8m
Cash & Short-Term Investments 384m
Receivables 177.6m
Other Current Assets 185.2m
Non-Current Assets 729.7m
Long-Term Investments 2.2m
PP&E 712.9m
Intangibles 10.9m
Other Non-Current Assets 3.7m
Current Liabilities 356.5m
Accounts Payable 308.7m
Accrued Liabilities 202.5m
Other Current Liabilities -154.7m
Non-Current Liabilities 388.2m
Long-Term Debt 355.8m
Other Non-Current Liabilities 32.5m
Efficiency

Free Cash Flow Analysis
TOT BIOPHARM International Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
TOT BIOPHARM International Co Ltd

Revenue
1.1B CNY
Cost of Revenue
-308.3m CNY
Gross Profit
758.6m CNY
Operating Expenses
-740.5m CNY
Operating Income
18.1m CNY
Other Expenses
-10.9m CNY
Net Income
7.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

TOT BIOPHARM International Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
46/100
Profitability
Score

TOT BIOPHARM International Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

TOT BIOPHARM International Co Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
40/100
Solvency
Score

TOT BIOPHARM International Co Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
TOT BIOPHARM International Co Ltd

There are no price targets for TOT BIOPHARM International Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

TOT BIOPHARM International Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for TOT BIOPHARM International Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one TOT BIOPHARM International Co Ltd stock?

The intrinsic value of one TOT BIOPHARM International Co Ltd stock under the Base Case scenario is 3.84 HKD.

Is TOT BIOPHARM International Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2.5 HKD, TOT BIOPHARM International Co Ltd is Undervalued by 35%.

Back to Top